Skip to main content
. 2022 Jul 4;13:939631. doi: 10.3389/fimmu.2022.939631

Figure 4.

Figure 4

Patient care, therapy selection, and balance between desired effects and potential side effects (with special emphasis in the liver) of gender-affirming hormone therapy (GAHT) for transgender populations. AMPK, D2R, dopamine D2 receptor; GnRH, gonadotropin-releasing hormone; MC, menstrual cycle.